Institutional Ownership
Integra Lifesciences Hldgs C
CUSIP 457985208COM NEWIARTQ1 2026
13D / 13G Filings
48
Schedule 13D/13G on record
Beneficial Filers
15
Distinct reporting persons
Largest Stake
14.3%
Max % of class reported
Institutional Holders
193
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
48 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Fuller &Amp; Thaler Asset Management, Inc. | 13G/A | 4.7% | 3.64M | SEC |
| 2 | Nov 6, 2025 | Invesco Ltd. | 13G/A | 4.5% | 3.49M | SEC |
| 3 | Aug 5, 2025 | Morgan Stanley | 13G/A | 4.3% | 3.38M | SEC |
| 4 | Jul 17, 2025 | Blackrock, Inc. | 13G/A | 13.2% | 10.28M | SEC |
| 5 | Jul 9, 2025 | Rubric Capital Management LP | 13G/A | 9.5% | 7.35M | SEC |
| 6 | May 14, 2025 | Rubric Capital Management LP | 13G | 6.0% | 4.64M | SEC |
| 7 | May 9, 2025 | Invesco Ltd. | 13G | 5.3% | 4.11M | SEC |
| 8 | Nov 12, 2024 | Capital Research Global Investors | 13G/A | 1.7% | 1.30M | SEC |
| 9 | Nov 12, 2024 | Fuller & Thaler Asset Management, Inc. | 13G | 5.1% | 3.97M | SEC |
| 10 | Aug 12, 2024 | Vanguard Group Inc | 13G/A | 10.1% | 7.80M | SEC |
38 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Integra Lifesciences Hldgs C.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 10.32M | $97.21M |
| 2 | Rubric Capital Management LP | 7.75M | $73.04M |
| 3 | Paradigm Capital Management Inc/Ny | 4.01M | $37.80M |
| 4 | Morgan Stanley | 3.58M | $33.76M |
| 5 | Fuller & Thaler Asset Management, Inc. | 3.53M | $33.25M |
| 6 | Invesco Ltd. | 3.49M | $32.83M |
| 7 | State Street Corp | 2.89M | $27.19M |
| 8 | Dimensional Fund Advisors LP | 2.77M | $26.14M |
| 9 | Neuberger Berman Group LLC | 2.12M | $19.90M |
| 10 | Goldman Sachs Group Inc | 1.88M | $17.68M |